|
|
 |
|
Viewing report
|
|
|
|
Global In Vitro Diagnostics (IVD) Market Report: 2011 Edition
Koncept Analytics, Oct 2011, Pages: 48
In-vitro diagnostics (IVD), which includes testing from assays in a controlled environment outside the living organism, accounts for a major share in the global diagnostics market. Despite the global economic crisis, the market registered growth mainly on the back of introduction of new technologies, rapidly ageing population, increasing health awareness, and increasing contribution of the emerging countries.
On the basis of technology, Immunochemistry dominates the global IVD market, followed by Diabetes Care. North America represents the largest IVD market worldwide, followed by Europe and Japan. In the coming years, these mature markets would offer less potential for growth, whereas the emerging markets like Asia Pacific and Latin America would offer immense potential for growth.
Point of Care (POC), which offers diagnostic services at or near the site of the patient, is more convenient than the traditional tests as it brings the result immediately for fast and better treatment. Some of the other segments which are likely to register significant growth rates in the coming years include Molecular Diagnostics, and Anatomic Pathology. The growth in some of the aforementioned segments, together with the increasing healthcare expenditure, rapidly ageing population, increasing diabetic population, as well as the rising per capita income in the emerging countries, will benefit the IVD market in the years to come.
Global IVD industry is consolidated with the top nine players accounting for a major share. In fact, the ongoing mergers and acquisitions in the industry are expected to further increase consolidation. Roche is the market leader, followed by Abbott, Siemens and Johnson & Johnson.
Key Features:
The report entitled “Global In-vitro Diagnostics (IVD) Market: 2011 Edition”, presents the global market for in-vitro diagnostics as well as its segments. The two leading IVD markets, European Union and North America as well as the two emerging markets for IVD, India and China are being profiled in the report. The report discusses the major drivers promising future growth. Since the IVD industry is highly regulated, the regulatory structure, with a focus on Europe and the US is also featured. The major players in the IVD industry have been profiled in this report, highlighting their financials as well as strategies for growth.
By combining SPSS Inc.'s data integration and analysis capabilities with relevant findings, the report forecasts the future growth of the industry. Various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Also available
Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition
|
|
|
|
